Humana Inc. (NYSE:HUM) Stake Lifted by Marshall Wace LLP

Marshall Wace LLP increased its stake in Humana Inc. (NYSE:HUM) by 118.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,425,302 shares of the insurance provider’s stock after acquiring an additional 774,085 shares during the period. Humana makes up approximately 0.7% of Marshall Wace LLP’s investment portfolio, making the stock its 11th biggest position. Marshall Wace LLP owned approximately 1.18% of Humana worth $532,564,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Pzena Investment Management LLC lifted its stake in Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares during the last quarter. Sanders Capital LLC acquired a new stake in Humana during the fourth quarter valued at approximately $489,300,000. Ontario Teachers Pension Plan Board lifted its stake in Humana by 11,647.2% during the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after purchasing an additional 1,050,459 shares during the last quarter. Putnam Investments LLC lifted its stake in Humana by 550.3% during the fourth quarter. Putnam Investments LLC now owns 875,489 shares of the insurance provider’s stock valued at $400,808,000 after purchasing an additional 740,858 shares during the last quarter. Finally, Steadfast Capital Management LP acquired a new stake in Humana during the first quarter valued at approximately $158,813,000. 92.38% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently commented on HUM. Robert W. Baird began coverage on shares of Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 target price for the company. Truist Financial increased their target price on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research note on Monday, July 15th. JPMorgan Chase & Co. upped their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research report on Wednesday, August 21st. Morgan Stanley started coverage on shares of Humana in a research report on Monday, June 24th. They issued an “equal weight” rating and a $374.00 price target for the company. Finally, Cantor Fitzgerald restated a “neutral” rating and issued a $395.00 price target on shares of Humana in a research report on Friday. Thirteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $398.70.

Humana Stock Up 0.8 %

Humana stock opened at $312.74 on Tuesday. The firm’s 50 day moving average price is $356.28 and its two-hundred day moving average price is $345.36. Humana Inc. has a twelve month low of $298.61 and a twelve month high of $530.54. The firm has a market cap of $37.69 billion, a PE ratio of 19.47, a P/E/G ratio of 2.56 and a beta of 0.50. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same quarter in the prior year, the business posted $8.94 EPS. Humana’s quarterly revenue was up 10.4% on a year-over-year basis. On average, research analysts predict that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a dividend yield of 1.13%. Humana’s dividend payout ratio (DPR) is 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.